Search for on  
Saturday, July 04, 2009
     
 Home
 About CWA
 Join CWA
 Give/Donate
- Donate Now
- More Ways to Give
 Get Involved
- Federal
- State/Local
 Media Center
- CWA Experts
- Press Releases
- CWA In The News
- CWA Op/Eds
 Legislation
 Beverly LaHaye
 Institute
 Culture and Family Issues
 Legal Studies
 Family Voice
- Subscribe Online!
 Multimedia
 Shop CWA
 About CWA
 CWALAC
 Project 535
 Employment
 Internships
 Brochures
 Fact Cards
 Recently on CWA
 Links

CWA of VA - Now More Than Ever
October 15, 2009
Forest, VA


 

CWA Calls on FDA to Act After Another Woman Dies From Abortion Pill     9/22/2003

Surely women should not be treated as collateral damage in the pursuit of making abortion accessible.

Washington, D.C. — Concerned Women for America (CWA) renewed its call for the FDA to withdraw its approval of the abortion pill RU-486 after reports of another woman’s death. Eighteen-year-old Holly Patterson died from an infection caused by fragments of her baby left in her uterus after she took RU-486 at a Planned Parenthood facility in California. The facility's procedure for administering RU-486, advertised on the Web site of Planned Parenthood Golden Gate, deviates from at least two of the FDA's requirements, that: 1) the drug not be used after 49 days gestation, and 2) the second drug in the regimen, misoprostol, be taken in a doctor’s office or clinic.

CWA, the American Association of Pro-Life Obstetricians and Gynecologists and the Christian Medical Association have challenged the FDA approval of RU-486 and its subsequent misuse by abortionists. The Citizen Petition details the numerous violations committed by the FDA in its approval of RU-486, along with descriptions of how abortionists continue to violate the insufficient requirements handed down by the FDA.

Monty Patterson, Holly’s father, speaks from first-hand experience on how these violations led to his daughter’s death. He told the San Francisco Chronicle, “The medical community treats this as a simple pill you take, as if you’re getting rid of a headache. The procedure, the follow-ups, it’s all too lackadaisical. The girl gets a pill. Then she’s sent home to do the rest on her own. There are just too many things that can go wrong.”

Since RU-486 received U.S. approval, Danco, the distributor of the drug, has reported 400 complications to the FDA. These include one woman who died from an ectopic pregnancy, another who suffered a heart attack, and two 15-year olds who contracted life-threatening infections. Another woman in Canada died from a bacterial infection.

“The FDA has the power to protect women from this dangerous drug,” stated Wendy Wright of CWA. “We grieve with the Patterson family over the loss of their daughter. Her parents – who wanted to be a part of her life and decisions – needlessly lost a daughter and grandchild, while Planned Parenthood pockets the fee and continues to fight against parental notification laws.”

“RU-486 has only one purpose – to kill a human being. But – as we have repeatedly warned – it also threatens women’s lives and health. Surely women should not be treated as collateral damage in the pursuit of making abortion accessible.”



Bookmark and Share

For Information Contact:
Demi Bardsley
(202) 488-7000, ext. 134
media.cwfa.org

Printer Friendly Version

Recent Articles
Fetal Homicide: Always Two Victims of Violence
CWALAC Objects to “Ambassador for Abortion” Bill
Pro-Life Activism in the Aftermath of Tiller's Murder
Statement on Killing of Late-Term Abortionist George Tiller
California Supreme Court Yields to “We the People”
New! Research Must Respect Life
Crouse Laments the President’s Spin at Notre Dame
A Solution to the Notre Dame-Obama Conflict
Gallup Shows More Americans Pro-Life
Guest Commentary! Is Obama the First Pro-Euthanasia President?

 

 
 

 

Concerned Women for America
1015 Fifteenth St. N.W., Suite 1100
Washington, D.C. 20005
Phone: (202) 488-7000
Fax: (202) 488-0806

Feedback / Questions? || Problem with this page? || Archives



 
    ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... .....